
Overview
Errol L. Bush, M.D., FACS, is a thoracic surgeon and surgical director of the Advanced Lung Disease and Lung Transplant Program for the Johns Hopkins Comprehensive Transplant Center. He also serves as director of the Ex vivo Lung Perfusion Program (EVLP). Dr. Bush specializes in the surgical treatment of chronic and end stage lung diseases, as well as benign (non-cancerous) and malignant (cancerous) diseases and lesions of the chest. He is skilled in minimally invasive operations such as video-assisted thoracoscopic surgery (VATS), a type of thoracic surgery performed using a small video camera that is introduced into the patient's chest via a scope to treat lung and esophageal cancers. Dr. Bush also has experience with extracorporeal membrane oxygenation (ECMO), a technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs can no longer serve their function. His research interests include investigations of outcomes and health disparities related to lung cancer, lung transplant and ECMO patients. Dr. Bush is currently leading several open clinical trials.
Dr. Bush is rated as an Experienced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Lung Cancer, Pulmonary Fibrosis, Fibrosing Mediastinitis, Lung Transplant, and Heart Transplant.
His clinical research consists of co-authoring 111 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Cardiogenic Shock.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
601 North Caroline Street, Floor 8, Floor 8, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Inova Cardiac Surgery-Fairfax
Daniel Tang is a Thoracic Surgeon in Fairfax, Virginia. Dr. Tang is rated as a Distinguished provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Cardiac Tamponade, Aortic Dissection, Heart Transplant, and Coronary Artery Bypass Graft (CABG).
The Johns Hopkins Hospital
Glenn Whitman, M.D., joined the Johns Hopkins Division of Cardiac Surgery in 2009 as associate professor of surgery. His training began at the University of Pennsylvania, where he was a resident in surgery from 1979 to 1984. He then finished his general surgery training and then completed his training as a cardiothoracic surgeon at the University of Colorado. Thereafter, Dr. Whitman became an assistant professor at the University of Colorado and chief of cardiothoracic surgery at the Denver Veteran’s Administration Hospital, where he remained for two years. In 1990, he returned to his home city of Philadelphia, where he became chief of cardiac surgery at the Medical College of Pennsylvania, formerly Women’s Medical College, the first medical school in the United States to accept women. Dr. Whitman remained there for eight years before moving to the University of Maryland as chief of cardiac surgery. He has served as the director of transplantation and United Network for Organ Sharing representative at Temple University Hospital in Philadelphia, as well as its director of perioperative services, managing preadmission testing, the operating room, and the post-anesthesia care unit. In 2007, he left Temple for Thomas Jefferson Hospital, taking over the responsibilities of running the cardiac surgery intensive care unit. In summer 2009, he was returned to Baltimore to run the cardiac surgery intensive care unit and oversee the performance improvement/quality assurance program for cardiac surgery at Johns Hopkins. Dr. Whitman’s initial research interests were in cardiac ischemia-reperfusion injury and P31 nuclear magnetic resonance of cardiac bioenergetics, for which he received both National Institutes of Health and Department of Veterans Affairs funding. He has since become involved with quality outcome, and has presented at the American College of Surgeons and the Society of Thoracic Surgeons on the difficulties associated with performance improvement and quality assurance in the field of health care, particularly in the ICU. This past year, Dr. Whitman has stepped down from his role as the Chair of the Society of Thoracic Surgery Workforce on Critical Care, a role he had held since 2014. He continues to participate in the content of the Annual Meetings for the Society of Thoracic Surgery, The American Association of Thoracic Surgery, and The STS Fall Critical Care meetings as the Programmatic Co-Chair for Perioperative Care. This past year he has participated in two major consensus statements on postcardiotomy shock (see below) and low ejection fraction CABG patients (awaiting review). 2020 EACTS/ELSO/STS/AATS ExpertConsensus on Post-CardiotomyExtracorporeal Life Support in Adult Patients Ann Thorac Surg 2012;111:327-69. Dr. Whitman is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Restrictive Cardiomyopathy (RCM), Hemolysis, Heart Bypass Surgery, and Heart Transplant.
Medstar Heart Institute LLC
Keki Balsara is a Thoracic Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Balsara is rated as an Advanced provider by MediFind in the treatment of Cardiogenic Shock. His top areas of expertise are Cardiogenic Shock, Endocarditis, Infective Endocarditis, Heart Transplant, and Lung Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung TransplantDr. Bush isElite. Learn about Lung Transplant.
- Advanced
- Heart TransplantDr. Bush isAdvanced. Learn about Heart Transplant.
- Lung CancerDr. Bush isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Cardiogenic ShockDr. Bush isExperienced. Learn about Cardiogenic Shock.
- Collapsed LungDr. Bush isExperienced. Learn about Collapsed Lung.
- EmphysemaDr. Bush isExperienced. Learn about Emphysema.
- Fibrosing MediastinitisDr. Bush isExperienced. Learn about Fibrosing Mediastinitis.
- GastrostomyDr. Bush isExperienced. Learn about Gastrostomy.
